/
Other
Catheter
6
Pipeline Programs↗
8
Active Trials↗
7
Companies Involved↗
Catheter is an early-stage landscape with 6 programs across 7 companies. The most active players are Regeneron.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical4
Phase 1
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
53
clinical trials
Completed24 · 45%
Unknown status8 · 15%
Terminated7 · 13%
Withdrawn6 · 11%
Recruiting4 · 8%
Enrolling by invitation3 · 6%
Other1 · 2%
Clinical Trials
Trial Activity
53 trials
Heparin vs Placebo for Cardiac Catheterization
Recruiting·LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·Phase 3·NCT04374799·1,623 enrolled
Diphenhydramine in Catheter Related Bladder Discomfort
Enrolling by invitation·—·N/A·NCT06345261·104 enrolled
The Effect of Ultrasound Guidance Versus Landmark Technique on the Number of Needle Redirections in Internal Jugular Vein Catheterization
Enrolling by invitation·SSaglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital·N/A·NCT07701746·144 enrolled
The Effect of Ultrasound Guidance Versus Landmark Technique on Catheter Malposition in Internal Jugular Vein Catheterization
Enrolling by invitation·SSaglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital·N/A·NCT07701720·204 enrolled
Norepinephrine Administration Through a Midline Catheter in an Intermediate Care Unit
Completed·—·N/A·NCT06121115·473 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)